Dr Keri Hildick
Head of Global Business Development
Dr Keri Hildick leads the Company’s global Business Development function; developing new business opportunities and strategic partnerships. Keri has engaged with Key Opinion Leaders across the industry to develop a deep understanding of the key challenges in liver disease, representing Perspectum at International Radiology and Liver Congresses, and serves as a member of the Liver Forum Paediatric NASH Panel.
Keri holds a BSc (Hons) in Pharmacology from the University of Edinburgh and a PhD in molecular neurobiology at the University of Bristol. Before joining Perspectum, Keri worked at GlaxoSmithKline in vitro pharmacology and molecular discovery research, and at the Royal Society in science communications, before moving into the clinical healthcare sector as a Research Analyst in liver diseases and HIV infection.